LONG-TERM EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY BASELINE BODY MASS INDEX

被引：2
|
作者：
Chupp, Geoffrey L.
Lugogo, Njira L.
Wechsler, Michael E.
Lawson, Kaitlyn
Lindsley, Andrew
Spahn, Joe D.
Ambrose, Christopher
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.075
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：9A / 14A
页数：6
相关论文
共 50 条
  • [41] Dupilumab efficacy in severe asthma exacerbations by different baseline patient characteristics in patients with uncontrolled persistent asthma
    Fabbri, L. M.
    Bernstein, J. A.
    Staudinger, H.
    Maroni, J.
    Rowe, P.
    Jayawardena, S.
    Joish, V. N.
    Eckert, L.
    Amin, N.
    Akinlade, B.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    ALLERGY, 2017, 72 : 108 - 109
  • [42] Effect of Tezepelumab on Airway Hyperresponsiveness by Baseline Blood Eosinophil Count in Patients With Severe, Uncontrolled Asthma in the Phase 2 CASCADE Study
    Brightling, C. E.
    O'Byrne, P. M.
    Porsbjerg, C.
    Boulet, L.
    Martin, N.
    Molfino, N. A.
    Megally, A.
    Griffiths, J. M.
    Clarke, D.
    Martin, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [43] Body Mass Index and Long-Term Outcomes in Patients With Colorectal Cancer
    Shahjehan, Faisal
    Merchea, Amit
    Cochuyt, Jordan J.
    Li, Zhuo
    Colibaseanu, Dorin T.
    Kasi, Pashtoon Murtaza
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [44] Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR (vol 16, pg 915, 2023)
    Laidlaw, Tm
    Menzies-Gow, A.
    Caveney, S.
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 1053 - 1053
  • [45] Effect of Tezepelumab on Exercise Tolerance in Patients With Severe, Uncontrolled Asthma From the NAVIGATOR Study
    Lugogo, N. L.
    Kraft, M.
    Corren, J.
    Martin, N.
    Shenoy, K. V.
    Shenoy, S. F.
    Chandarana, S.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [46] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY SMOKING HISTORY: POST HOC ANALYSIS OF THE PHASE 3 NAVIGATOR STUDY
    Castro, Mario
    Cook, William
    Ambrose, Christopher
    Lindsley, Andrew W.
    Hunter, Gillian
    Martin, Neil
    Ponnarambil, Sandhia
    CHEST, 2022, 162 (04) : 35A - 36A
  • [47] Characteristics of exacerbations in patients with severe, uncontrolled asthma who received tezepelumab versus placebo
    Bourdin, Arnaud
    Wechsler, Michael E.
    Brightling, Christopher E.
    Korn, Stephanie
    Brusselle, Guy
    Heaney, Liam G.
    Ponnarambil, Sandhia
    Hunter, Gillian
    Lindsley, Andrew W.
    Ambrose, Christopher S.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [48] Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR)
    Pavord, Ian D.
    Hoyte, Flavia C. L.
    Lindsley, Andrew W.
    Ambrose, Christopher S.
    Spahn, Joseph D.
    Roseti, Stephanie L.
    Cook, Bill
    Grif, Janet M.
    Hellqvist, Asa
    Martin, Nicole
    Llanos, Jean-Pierre
    Martin, Neil
    Colice, Gene
    Corren, Jonathan
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : 587 - 597.e3
  • [49] Tezepelumab improves patient-reported outcomes in patients with severe, uncontrolled asthma in PATHWAY
    Corren, Jonathan
    Garcia Gil, Esther
    Griffiths, Janet M.
    Parnes, Jane R.
    van der Merwe, Rene
    Salapa, Kinga
    O'Quinn, Sean
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (02) : 187 - 193
  • [50] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma With Aspirin-exacerbated Respiratory Disease: Results From the NAVIGATOR Study
    Bernstein, Jonathan
    Laidlaw, Tanya
    Buccheit, Kathleen
    Cahill, Katherine
    Martin, Nicole
    Ponnarambil, Sandhia
    Parikh, Bhavini
    Ambrose, Christopher
    Lindsley, Andrew
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB101 - AB101
12345